Menu Login / Registration Search
CZ

CLIA CMV IgM

Chemiluminescence kit for the detection of IgM antibodies to Cytomegalovirus in human serum or plasma

Available
Catalog Number: CL-CMM100
Size: 100 tests
Regulatory status: CE IVD
Clinical topic: Infectious Diseases
Diagnostic panel: Herpes Viruses
TORCH
Producer: TestLine Clinical Diagnostics s.r.o.
CLIA CMV IgM
  • Detection of IgM antibodies to Human Cytomegalovirus (CMV)
  • Detection of CMV infection
  • Disease staging
  • Intended for human serum, citrate plasma
  • Purified and inactivated antigen isolated from CMV AD 169 strain with a high content of specific immunodominant epitopes used

Human cytomegalovirus (CMV, Human Herpesvirus 5, HHV 5) is a member of the Herpetoviridae family. In humans, it is mainly transmitted by the respiratory apparatus or urogenital tract. The disease is usually asymptomatic or mild, the latent infection can be reactivated in pregnancy, serious disease, stress, or immunosuppressive treatment. An individuum can be reinfected by a different CMV strain. CMV infection during pregnancy causes developmental defects. The virus is easily transmitted through the placenta during primary infection (in 30-50 % of cases); during the reactivation stage, transplacental transmission occurs in only 1% of cases. CMV infection belongs to the TORCH syndrome.

The most widely used approach in serological diagnostics of CMV infection is the detection of specific IgA, IgM, and IgG antibodies.

Antibodies of IgA class are a sign of an active infection – primary infection as well as reactivation. Production of IgM antibodies usually increases a few weeks after infection or reactivation and then decreases slowly. IgM determination alone cannot discriminate primary infection from reactivation. Specific IgG seroconversion indicates primary infection.

Detection of IgG antibodies to CMV is also used as a standard method for screening blood donors.

Technical specifications

Technical data
References
Related Products
Downloads

Technical data

Assay stability30 days on board stability / In use stability until the expiration date at storage temperature 2-8 °C
Sample matrix Serum, Plasma
Measuring range0.5 - 160 U/ml
Assay/kit contentReagent Cartridge with specific reagents for the assay, magnetic particles, calibrators
Complementary productsAnchor® Tips, Stackable Cuvette, KleeYa Trigger Pack, KleeYa Wash buffer
Note

The kits are CE-IVD certified and intended for professional use.

References

  • Blackburn NK, Besselaar TG, Schoub BD, O'Connell KF. Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity. J Med Virol. 1991 Jan;33(1):6-9. doi: 10.1002/jmv.1890330103. PMID: 1849983.
    See more on PubMed
  • Bodéus M, Feyder S, Goubau P. Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women. Clin Diagn Virol. 1998 Jan;9(1):9-16. doi: 10.1016/s0928-0197(97)10016-2. PMID: 9562853.
    See more on PubMed
  • Boeckh M, Boivin G. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin Microbiol Rev. 1998 Jul;11(3):533-54. doi: 10.1128/CMR.11.3.533. PMID: 9665982; PMCID: PMC88895.
    See more on PubMed
  • Dussaix E, Chantot S, Harzic M, Grangeot-Keros L. CMV-IGG avidity and CMV-IGM concentration in both immunocompromised and immunocompetent patients. Pathol Biol (Paris). 1996 May;44(5):405-10. PMID: 8758485.
    See more on PubMed
  • Grangeot-Keros L, Mayaux MJ, Lebon P, Freymuth F, Eugene G, Stricker R, Dussaix E. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis. 1997 Apr;175(4):944-6. doi: 10.1086/513996. PMID: 9086155.
    See more on PubMed
  • Joassin L, Reginster M. Elimination of nonspecific cytomegalovirus immunoglobulin M activities in the enzyme-linked immunosorbent assay by using anti-human immunoglobulin G. J Clin Microbiol. 1986 Mar;23(3):576-81. doi: 10.1128/jcm.23.3.576-581.1986. PMID: 3007570; PMCID: PMC268697.
    See more on PubMed
  • Lazzarotto T, Varani S, Guerra B, Nicolosi A, Lanari M, Landini MP. Prenatal indicators of congenital cytomegalovirus infection. J Pediatr. 2000 Jul;137(1):90-5. doi: 10.1067/mpd.2000.107110. PMID: 10891828.
    See more on PubMed
  • Pappin A, Grissom M, Mackay W, Huang Y, Yomtovian R. Stability of cytomegalovirus antibodies in plasma during prolonged storage of blood components. Clin Diagn Lab Immunol. 1995 Jan;2(1):25-9. doi: 10.1128/cdli.2.1.25-29.1995. PMID: 7719908; PMCID: PMC170095.
    See more on PubMed
  • Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev. 2002 Oct;15(4):680-715. doi: 10.1128/CMR.15.4.680-715.2002. PMID: 12364375; PMCID: PMC126858.
    See more on PubMed

Related Products

Downloads

Safety information

Product brochure

Declaration of conformity

EC Certificate

Find documents for the lot

Do you want to learn more about products? We're here for you.

Please fill in
all fields
marked *
Up